391 Shares in Colgate-Palmolive (NYSE:CL) Acquired by Baron Silver Stevens Financial Advisors LLC
Baron Silver Stevens Financial Advisors LLC bought a new position in Colgate-Palmolive (NYSE:CL) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 391 shares of the company’s stock, valued at approximately $33,000.
Other large investors have also added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its stake in shares of Colgate-Palmolive by 2.2% during the fourth quarter. Bank of New York Mellon Corp now owns 18,645,998 shares of the company’s stock valued at $1,594,421,000 after acquiring an additional 408,068 shares in the last quarter. Northern Trust Corp increased its stake in shares of Colgate-Palmolive by 1.1% during the fourth quarter. Northern Trust Corp now owns 10,448,953 shares of the company’s stock valued at $893,490,000 after buying an additional 116,598 shares during the period. Norges Bank bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $742,997,000. Price T Rowe Associates Inc. MD lifted its stake in Colgate-Palmolive by 2.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,159,901 shares of the company’s stock worth $526,700,000 after acquiring an additional 138,990 shares during the period. Finally, Nuveen Asset Management LLC grew its holdings in Colgate-Palmolive by 0.8% during the 4th quarter. Nuveen Asset Management LLC now owns 5,914,041 shares of the company’s stock worth $505,709,000 after acquiring an additional 49,271 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.
Shares of NYSE CL opened at $79.62 on Thursday. The company has a market capitalization of $67.48 billion, a PE ratio of 25.44, a price-to-earnings-growth ratio of 3.83 and a beta of 0.59. The company has a debt-to-equity ratio of 6.50, a quick ratio of 0.62 and a current ratio of 0.97. The company’s fifty day moving average price is $76.89 and its 200 day moving average price is $80.38. Colgate-Palmolive has a 1 year low of $65.54 and a 1 year high of $86.41.
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 14th. Shareholders of record on Wednesday, April 21st will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Tuesday, April 20th. This represents a $1.80 dividend on an annualized basis and a yield of 2.26%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.44. Colgate-Palmolive’s dividend payout ratio is currently 62.19%.
In other news, VP Philip G. Shotts sold 346 shares of the business’s stock in a transaction dated Tuesday, February 16th. The shares were sold at an average price of $77.16, for a total transaction of $26,697.36. Following the completion of the sale, the vice president now owns 41,128 shares of the company’s stock, valued at $3,173,436.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider John W. Kooyman sold 463 shares of the company’s stock in a transaction dated Tuesday, February 16th. The stock was sold at an average price of $77.16, for a total transaction of $35,725.08. Following the transaction, the insider now owns 7,160 shares of the company’s stock, valued at approximately $552,465.60. The disclosure for this sale can be found here. Over the last three months, insiders sold 30,810 shares of company stock worth $2,418,650. 0.78% of the stock is owned by corporate insiders.
CL has been the topic of a number of recent research reports. Berenberg Bank upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $76.00 price objective on the stock in a research note on Tuesday, January 26th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $83.00 price target on the stock. in a report on Thursday, January 28th. Royal Bank of Canada lowered Colgate-Palmolive from an “outperform” rating to a “sector perform” rating and set a $90.00 price target for the company. in a research report on Monday, January 4th. Sanford C. Bernstein assumed coverage on Colgate-Palmolive in a research report on Tuesday, January 19th. They set an “underperform” rating and a $77.00 price objective on the stock. Finally, Credit Suisse Group upgraded shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and boosted their target price for the stock from $70.00 to $80.00 in a report on Monday, February 1st. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and two have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $81.91.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.
Featured Article: Find a Trading Strategy That Works
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.